Epitome Therapeutics

Epitome Therapeutics

HealthBiotechnology📍 Vienna, Austria

Epitome Therapeutics is a BioTech company focused on advancing precision epigenome editing for programmable gene expression. The company aims to develop new therapeutic approaches based on the precise regulation of gene expression, with a notable emphasis on their CADENCE platform. This funding will help them build their team and advance their development programmes.

Visit website ↗
Total raised
$4.3M
tracked to date
Latest round
Pre-seed
Jun 30, 2026
Known investors
3
led by XISTA Science Ventures

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Austria.

Claim this profile →

Funding history

  1. 1
    $4.3MPre-seedJun 30, 2026

    Led by XISTA Science Ventures

    Announcement ↗

Founder

Dr. Guido Gualdoni
Dr. Guido Gualdoni
Co-founder and CEO

Investors in Epitome Therapeutics

Backers from this company's tracked funding rounds.

  • XXISTA Science VenturesLead investorVC firm
  • CCaesar VenturesVC firm
  • NNavec Venture Holding GmbHVC firm

Epitome Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile